Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Marabelle

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2018
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)A Marabelle, R Andtbacka, K Harrington, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug developmentC B Westphalen, D Martins-Branco, J R Beal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variantsM Messaoudene, T P Mourikis, J Michels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2024
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerM Ambrosini, B Rousseau, P Manca, et al.
Nature Communications|September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanomaN Jacquelot, M P Roberti, D P Enot, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2018
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)A Marabelle, R Andtbacka, K Harrington, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug developmentC B Westphalen, D Martins-Branco, J R Beal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variantsM Messaoudene, T P Mourikis, J Michels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2024
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerM Ambrosini, B Rousseau, P Manca, et al.
Nature Communications|September 21, 2017
Predictors of responses to immune checkpoint blockade in advanced melanomaN Jacquelot, M P Roberti, D P Enot, et al.
Pageof 5